INTERNATIONAL PATENT: TESSERA THERAPEUTICS, INC. FILES APPLICATION FOR "EX VIVO DELIVERY OF LIPID NANOPARTICLES FOR DELIVERY OF GENE MODIFYING SYSTEMS TO T CELLS"

GENEVA, Aug. 13 -- TESSERA THERAPEUTICS, INC. (101 South Street, Suite 300Somerville, Massachusetts 02143) filed a patent application (PCT/US2025/014224) for "EX VIVO DELIVERY OF LIPID NANOPARTICLES FOR DELIVERY OF GENE MODIFYING SYSTEMS TO T CELLS" on Jan 31, 2025. With publication no. WO/2025/166314, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STEIN, Kassi Taylor (c/o Tessera Therapeutics, Inc.101 South Street, Suite 300Somerville, Massachusetts 02143), RODRIGUEZ, Jason John (c/o Tessera Therapeutics, Inc.101 South ...